Skip to main content
SpringerLink
Log in

Treat lupus nephritis according to disease presentation

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hahn BB. Systemic Lupus Erythematosus. In: Isselbacher KJ, et al., editors. Harrison’s principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994: 1643–8

    Google Scholar 

  2. Belmont MB. Lupus nephritis: treatment issues. BioDrugs 1999 Jan; 11(1): 7–19

    Article  PubMed  CAS  Google Scholar 

  3. Appel GB, Cohen DJ, Pirani CL, et al. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 1987; 83: 877–85

    Article  PubMed  CAS  Google Scholar 

  4. Austin HA III, Muenz LR, Joyce KM, et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689–95

    Article  PubMed  Google Scholar 

  5. Balow JE, Austin III HA, Muenz LR. Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med 1984; 311: 491–5

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treat lupus nephritis according to disease presentation. Drugs Ther. Perspect 14, 6–9 (1999). https://doi.org/10.2165/00042310-199914080-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199914080-00002

Keywords

Search

Navigation